Skip to Content

C25 (Rubraca 250 mg)

Generic Name: rucaparib

Pill with imprint C25 is White, Four-sided and has been identified as Rubraca 250 mg. It is supplied by Clovis Oncology, Inc..

Rubraca is used in the treatment of ovarian cancer; prostate cancer and belongs to the drug class PARP inhibitors. Rubraca 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C25

Rubraca 250 mg C25

Rubraca

Generic Name
rucaparib
Imprint
C25
Strength
250 mg
Color
White
Size
15.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
PARP inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Clovis Oncology, Inc.
Manufacturer
Clovis Oncology, Inc.
National Drug Code (NDC)
69660-0202
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type A potato, silicon dioxide, magnesium stearate, titanium dioxide, magnesium silicate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.